Management of Hematochezia
The initial management of hematochezia depends critically on hemodynamic stability: immediately stratify patients using shock index (heart rate/systolic BP), with unstable patients (shock index >1) requiring CT angiography for rapid localization, while stable patients with minor bleeding (Oakland score ≤8) can be safely discharged for urgent outpatient colonoscopy within 14 days 1.
Initial Risk Stratification
First, calculate the shock index (heart rate divided by systolic blood pressure):
- Shock index >1 = unstable patient
- Shock index ≤1 = stable patient
For stable patients, apply the Oakland score to categorize bleeding severity:
- Oakland score ≤8 points = minor bleed
- Oakland score >8 points = major bleed
This algorithmic approach determines your entire management pathway 1.
Management Based on Hemodynamic Status
Unstable Patients (Shock Index >1)
Proceed directly to CT angiography after initial resuscitation—this provides the fastest, least invasive method to localize bleeding before planning intervention 1. This is critical because:
- If contrast extravasation is seen on CTA, proceed immediately to catheter angiography with embolization (should be available within 60 minutes in centers with 24/7 interventional radiology) 1
- If CTA is negative, perform upper endoscopy immediately to rule out upper GI source, as hemodynamically unstable lower GI bleeding may actually originate from above 1
Critical pitfall: Never proceed to emergency laparotomy unless every radiological and endoscopic option has been exhausted 1.
Stable Patients with Major Bleeding (Oakland >8)
Admit to hospital for colonoscopy 1. These patients require inpatient monitoring and endoscopic evaluation, though the timing can be less urgent than for unstable patients.
Stable Patients with Minor Bleeding (Oakland ≤8)
Discharge for urgent outpatient colonoscopy within 14 days 1, 2. This is a strong recommendation that prevents unnecessary hospitalizations while ensuring timely investigation.
Resuscitation and Transfusion Strategy
Use restrictive transfusion thresholds to reduce mortality 1:
- Standard patients: Transfuse at Hb <70 g/L, target 70-90 g/L
- Cardiovascular disease patients: Transfuse at Hb <80 g/L, target 100 g/L
This evidence-based approach improves outcomes compared to liberal transfusion strategies.
Anticoagulation Management
Interrupt warfarin immediately at presentation 1. For unstable hemorrhage, reverse with prothrombin complex concentrate and vitamin K 1.
Restart timing depends on thrombotic risk:
- Low thrombotic risk: Restart warfarin at 7 days 1
- High thrombotic risk (prosthetic metal mitral valve, AF with prosthetic valve, <3 months post-VTE): Consider low molecular weight heparin at 48 hours 1
Antiplatelet Management
- Aspirin for primary prevention: Permanently discontinue 1
- Aspirin for secondary prevention: Do not routinely stop; if stopped, restart as soon as hemostasis achieved 1
This nuanced approach balances bleeding and thrombotic risks based on the indication for anticoagulation.
Key Clinical Pitfalls
- Don't assume lower GI source in unstable patients—up to 15% have upper GI bleeding presenting as hematochezia 1
- Don't rush to surgery—interventional radiology and endoscopy should be exhausted first 1
- Don't over-transfuse—restrictive strategies improve mortality 1
- Don't forget risk stratification—Oakland score prevents both unnecessary admissions and inappropriate discharges 1
The mortality from lower GI bleeding is typically related to comorbidity (3.4% overall, rising to 18-20% in hospitalized patients or those requiring ≥4 units transfusion), not exsanguination itself 1, making appropriate risk stratification and comorbidity management essential.